Genmab A (GMAB) Shares Repurchased (2023 - 2025)
Historic Shares Repurchased for Genmab A (GMAB) over the last 3 years, with Q3 2025 value amounting to -$24.0 million.
- Genmab A's Shares Repurchased rose 4418.6% to -$24.0 million in Q3 2025 from the same period last year, while for Dec 2025 it was -$627.0 million, marking a year-over-year increase of 4401.79%. This contributed to the annual value of -$430.0 million for FY2025, which is 2321.43% up from last year.
- According to the latest figures from Q3 2025, Genmab A's Shares Repurchased is -$24.0 million, which was up 4418.6% from -$560.0 million recorded in Q4 2024.
- Genmab A's 5-year Shares Repurchased high stood at -$24.0 million for Q3 2025, and its period low was -$560.0 million during Q4 2024.
- For the 3-year period, Genmab A's Shares Repurchased averaged around -$204.2 million, with its median value being -$80.0 million (2023).
- As far as peak fluctuations go, Genmab A's Shares Repurchased tumbled by 59135.8% in 2024, and later skyrocketed by 4418.6% in 2025.
- Over the past 3 years, Genmab A's Shares Repurchased (Quarter) stood at -$81.0 million in 2023, then plummeted by 591.36% to -$560.0 million in 2024, then surged by 95.71% to -$24.0 million in 2025.
- Its Shares Repurchased was -$24.0 million in Q3 2025, compared to -$560.0 million in Q4 2024 and -$43.0 million in Q3 2024.